2024-11-27 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Review

This report analyzes Colgate-Palmolive Co (CL), a leading global consumer products company that manufactures and sells oral hygiene, personal care, home care, and pet nutrition products.

**1. Performance vs. S&P 500 (VOO):**

Colgate-Palmolive's cumulative return of 48.34% significantly underperformed the S&P 500's return of 128.31% over the analyzed period.  The difference is -80.0%, placing it at the 6.9th percentile of its historical range of performance relative to the S&P 500 (-86.5% to 7.2%).  The provided CAGR data shows inconsistent performance compared to the S&P 500, with periods of underperformance and periods of slight outperformance, though generally lagging behind the market index.  The alpha consistently above 1 suggests outperformance in periods of market volatility. However, given the large negative cumulative return difference, this alone is not indicative of consistent overall superior performance.

**2. Recent Price Movement:**

* **Closing Price:** $95.34 (Last market: $96.64)
* **5-Day Moving Average:** $94.41
* **20-Day Moving Average:** $93.20
* **60-Day Moving Average:** $99.14

The recent price is below all three moving averages, suggesting a downtrend.  The price is close to the 5-day MA, indicating potential short-term support, but is significantly below the 60-day MA, indicating a longer-term bearish trend.  The gap between the last market price ($96.64) and the current close ($95.34) suggests a minor pullback, but not a significant drop.


**3. Technical Indicators:**

* **RSI (53.81):**  Suggests the stock is neither overbought nor oversold, indicating a neutral sentiment.
* **PPO (0.67):** A positive value suggests bullish momentum, but relatively low.
* **20-Day Relative Divergence (-0.4):** Shows a recent short-term downward trend relative to the benchmark.
* **Expected Return (0.0%):** This indicates that, based on the provided data, there's no expected outperformance over the S&P 500 in the long term (2+ years) using a buy-and-hold strategy.  This is in line with the underperformance shown by the cumulative return.


**4. Recent Financial Performance:**

The provided EPS and revenue data shows relatively stable revenue figures around $5 billion, with minor fluctuations. EPS shows a small downward trend from Q2 2024 to Q4 2024.  Additional context such as analyst estimates for the last quarter (2024-10-25) is needed to fully assess performance against expectations.

**5.  Financial Ratios (Analysis of provided data):**

* **Revenue and Profitability:**  Revenue has remained relatively consistent, while the profit margin shows a slight downward trend from a high of 61.08% in Q3 2024 to 58.54% in Q3 2023. This requires further investigation to determine the cause.

* **Capital and Profitability:**  ROE is highly volatile and exhibits extreme fluctuations, ranging from a massive positive value to a large negative value. This volatility in equity and ROE warrants further examination to understand the underlying drivers.  Abnormal ROE figures suggest significant changes in equity over the different quarters. More context or details concerning the nature of the company's equity during these periods is needed.


**6. News and Recent Issues:**

*(This section requires access to real-time news sources such as Shacknews, FINBOLD, etc., to provide current information on earnings announcements, analyst opinions, and market outlook. Please provide links to relevant news articles for a more comprehensive analysis.)*  Without specific news sources, a detailed analysis of recent market outlook, analyst opinions, and performance highlights cannot be provided.

**7. Comprehensive Analysis:**

Colgate-Palmolive has underperformed the S&P 500 significantly over the analyzed period, despite showing periods of positive alpha. Recent price action indicates a bearish trend, although technical indicators present a mixed signal.  Revenue is stable, but profit margins and ROE show concerning volatility. More information is required to assess the recent earnings report against expectations and to analyze news and analyst opinions regarding the company's future prospects. The highly volatile ROE figures require further investigation.


**8. Recommendations:**

Given the underperformance relative to the S&P 500, the bearish price trend, and the concerning volatility in financial ratios, a thorough investigation into the companyâ€™s recent performance, including a comparison to analyst expectations and a deeper dive into the reasons behind the ROE fluctuations, is recommended before making any investment decision.  The lack of expected return compared to the S&P 500, based on the provided data, also does not support an aggressive long-term investment strategy in CL, relative to an index fund like VOO.  Additional information, particularly concerning recent news, is critical for a complete assessment.
